IL153364A0 - PROCESS FOR THE PREPARATION OS SALTS OF 5-PHENYLPENTANOYL-(S)-ALANYL-(S)-ARGINYL-(S)-ALANYL-{(S)-2-[(r)-3-AMINO-2-OXOPYRROLIDIN-1-YL]PROPIONYL}-(S)-ALANYL-(S)-ARGINYL-(S)-ALANYL-4-AMINOPHENYLACETAMIDE, INTERMEDIATES USED IN THE PROCESS AND PROCESS FOR THEIR PREPARATION - Google Patents

PROCESS FOR THE PREPARATION OS SALTS OF 5-PHENYLPENTANOYL-(S)-ALANYL-(S)-ARGINYL-(S)-ALANYL-{(S)-2-[(r)-3-AMINO-2-OXOPYRROLIDIN-1-YL]PROPIONYL}-(S)-ALANYL-(S)-ARGINYL-(S)-ALANYL-4-AMINOPHENYLACETAMIDE, INTERMEDIATES USED IN THE PROCESS AND PROCESS FOR THEIR PREPARATION

Info

Publication number
IL153364A0
IL153364A0 IL15336401A IL15336401A IL153364A0 IL 153364 A0 IL153364 A0 IL 153364A0 IL 15336401 A IL15336401 A IL 15336401A IL 15336401 A IL15336401 A IL 15336401A IL 153364 A0 IL153364 A0 IL 153364A0
Authority
IL
Israel
Prior art keywords
alanyl
arginyl
preparation
aminophenylacetamide
phenylpentanoyl
Prior art date
Application number
IL15336401A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IL153364A0 publication Critical patent/IL153364A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rehabilitation Therapy (AREA)
  • Cell Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL15336401A 2000-07-22 2001-07-18 PROCESS FOR THE PREPARATION OS SALTS OF 5-PHENYLPENTANOYL-(S)-ALANYL-(S)-ARGINYL-(S)-ALANYL-{(S)-2-[(r)-3-AMINO-2-OXOPYRROLIDIN-1-YL]PROPIONYL}-(S)-ALANYL-(S)-ARGINYL-(S)-ALANYL-4-AMINOPHENYLACETAMIDE, INTERMEDIATES USED IN THE PROCESS AND PROCESS FOR THEIR PREPARATION IL153364A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0017979.6A GB0017979D0 (en) 2000-07-22 2000-07-22 Chemical process
PCT/GB2001/003228 WO2002008247A2 (en) 2000-07-22 2001-07-18 Process for the preparation of 5-phenylpentanoyl-ala-argl-{2-[3-amino-2-oxopyrrolidin-1-yl]propionyl}-ala-arg-ala-4-aminophenylacetamide

Publications (1)

Publication Number Publication Date
IL153364A0 true IL153364A0 (en) 2003-07-06

Family

ID=9896124

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15336401A IL153364A0 (en) 2000-07-22 2001-07-18 PROCESS FOR THE PREPARATION OS SALTS OF 5-PHENYLPENTANOYL-(S)-ALANYL-(S)-ARGINYL-(S)-ALANYL-{(S)-2-[(r)-3-AMINO-2-OXOPYRROLIDIN-1-YL]PROPIONYL}-(S)-ALANYL-(S)-ARGINYL-(S)-ALANYL-4-AMINOPHENYLACETAMIDE, INTERMEDIATES USED IN THE PROCESS AND PROCESS FOR THEIR PREPARATION

Country Status (18)

Country Link
US (1) US20040101864A1 (xx)
EP (1) EP1320538A2 (xx)
JP (1) JP2004504405A (xx)
KR (1) KR20030033001A (xx)
CN (1) CN1617881A (xx)
AU (1) AU2001270863A1 (xx)
BR (1) BR0112652A (xx)
CA (1) CA2412787A1 (xx)
CZ (1) CZ2003165A3 (xx)
GB (1) GB0017979D0 (xx)
HU (1) HUP0400485A3 (xx)
IL (1) IL153364A0 (xx)
MX (1) MXPA03000607A (xx)
NO (1) NO20030317L (xx)
NZ (1) NZ523217A (xx)
PL (1) PL365426A1 (xx)
WO (1) WO2002008247A2 (xx)
ZA (1) ZA200210247B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130286D0 (en) * 2001-12-19 2002-02-06 Astrazeneca Ab Chemical process
GB0130285D0 (en) * 2001-12-19 2002-02-06 Astrazeneca Ab Chemical process
US7923577B2 (en) 2009-04-27 2011-04-12 International Flavors & Fragrances Inc. Menthylcarboxamides and their use as cooling agents
JP6084021B2 (ja) * 2012-12-04 2017-02-22 富士通テン株式会社 表示システム、表示装置、表示方法、及び、プログラム
CN111848433B (zh) * 2020-07-14 2023-04-28 安徽中草香料股份有限公司 4-氨基苯基乙酰胺的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1155925A (en) * 1967-02-16 1969-06-25 Miles Lab Synthesis Of Octapeptides
US4152322A (en) * 1978-04-28 1979-05-01 Merck & Co., Inc. Process for selective reduction of nitroarginyl peptides with titanium (iii)
GB9702377D0 (en) * 1996-02-23 1997-03-26 Zeneca Ltd Peptide derivatives

Also Published As

Publication number Publication date
HUP0400485A3 (en) 2005-02-28
ZA200210247B (en) 2003-10-31
NO20030317L (no) 2003-03-14
BR0112652A (pt) 2003-07-01
WO2002008247A3 (en) 2002-10-17
PL365426A1 (en) 2005-01-10
CA2412787A1 (en) 2002-01-31
NO20030317D0 (no) 2003-01-21
HUP0400485A2 (hu) 2004-06-28
AU2001270863A1 (en) 2002-02-05
CZ2003165A3 (cs) 2003-04-16
US20040101864A1 (en) 2004-05-27
KR20030033001A (ko) 2003-04-26
MXPA03000607A (es) 2003-05-14
GB0017979D0 (en) 2000-09-13
CN1617881A (zh) 2005-05-18
JP2004504405A (ja) 2004-02-12
EP1320538A2 (en) 2003-06-25
WO2002008247A2 (en) 2002-01-31
NZ523217A (en) 2004-07-30

Similar Documents

Publication Publication Date Title
HUP0203425A3 (en) Quinazoline derivatives, process for their preparation and their use
HUP9900163A2 (en) Process for the preparation of sterol-and stanol-esters, and use thereof
AU2003233010A8 (en) Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
HUP0300527A3 (en) Pyrrolopyrimidinone derivatives, process of preparation and use
HUP0101375A3 (en) Novel cephalotaxane derivatives, process for their preparation and intermediates
HUP0302295A3 (en) Thienodibenzoazulene derivatives, process for their preparation and use thereof
HUP0202414A3 (en) Process for the preparation of perindopril, their analogous and their salts
CZ20012130A3 (cs) Piperazinový derivát, způsob jeho výroby a pouľití
IL159067A0 (en) METHODS FOR PREPARATION AND USE OF 1alpha,24 (S) -DIHYDROXYVITAMIN D2
AU4600200A (en) Salts of 2,2-dimethyl-1,3-dioxane intermediates and process for the preparation thereof
IL153364A0 (en) PROCESS FOR THE PREPARATION OS SALTS OF 5-PHENYLPENTANOYL-(S)-ALANYL-(S)-ARGINYL-(S)-ALANYL-{(S)-2-[(r)-3-AMINO-2-OXOPYRROLIDIN-1-YL]PROPIONYL}-(S)-ALANYL-(S)-ARGINYL-(S)-ALANYL-4-AMINOPHENYLACETAMIDE, INTERMEDIATES USED IN THE PROCESS AND PROCESS FOR THEIR PREPARATION
EP1617810A4 (en) PROCESS FOR THE PREPARATION AND USE OF 1ALPHA, 24 (S) -DIHYDROXYVITAMINE D2
HUP0103712A3 (en) Salts of paroxetine, process for their preparation and their pharmaceutical use
HUP0100146A3 (en) 3-(1-hydroxy-pentylidene)-5-nitro-3h-benzofuran-2-one, process for its preparation and use thereof
IL147862A0 (en) Process and intermediates for the preparation os isoxazolecaroxamides and analogues
IL129168A (en) Sulfonamides, process for their preparation and process for their reduction
HUP0204111A3 (en) Novel process for the preparation of alpha-(2,4-disulfophenyl)-n-tert-butylnitrone and pharmaceutically acceptable salts thereof
AU2001265969A1 (en) Process for the fermentative preparation of l-threonine
EP1273657A4 (en) NOVEL PROTEIN, METHOD FOR PRODUCTION AND USE
AU4263799A (en) Pyridyl-pyrazole derivatives, process for their preparation, and their use as herbicides
HUP9803041A3 (en) Thiazole derivatives, process for the preparation thereof, use thereof and pharmaceutical compositions containing them
AU1396400A (en) Process for the preparation of paroxetine hydrochloride
AU6481799A (en) Process for the preparation of paroxetine hydrochloride
AU1724201A (en) Process for the preparation of fluoxetine hydrochloride
HU9900123D0 (en) 1-isothiazolidinone derivatives of azetidine-2-one, processes for the preparation thereof and use thereof